About
Research interests include the design, execution, analysis and synthesis of cancer clinical trials; the assessment of quality of life and preferences; evidence-based medicine in clinical practice and medical education; patient-doctor communication; prognostication; and, management of genitourinary, lung, gynaecologic, and advanced cancers. The aim of my research has been to improve survival time, quality of life, prognostication, communication and decision-making for people affected by cancer.
Other Appointments
- Professor of Oncology and Clinical Epidemiology, University of Sydney
- Consultant Medical Oncologist, Chris O’Brien Lifehouse, Sydney
- Consultant Medical Oncologist, Concord Hospital, Sydney
Key Accomplishments
- Pivotal studies establishing the benefits of chemotherapy and targeted drugs for cancers of the prostate, testis, kidney, lung, breast and ovary
- Presenting information about prognosis as best, worst and typical scenarios for survival time
- Preference studies documenting the benefits patients judge necessary to make adjuvant therapy worthwhile in breast, lung, colorectal, endometrial, and kidney cancers
- Leadership of the Asia-Pacific Clinical Oncology Research Initiative (ACORD) from 2008-2021
Education / Honors
- Cancer Achievement Award 2019, Medical Oncology Group of Australia
- Mentoring and Leadership Award 2016, NHMRC Clinical Trials Centre
- Excellence in Mentoring Award 2009 (Academic and Research), Royal Australasian College of Physicians
- MSc Clinical Epidemiology, University of Toronto, Canada 1996
- Fellowship, Royal Australasian College of Physicians, 1992
- MBBS, University of NSW, Sydney Australia, 1984
Please Leave a Review or Suggestion